Journal
ALLERGY
Volume 75, Issue 7, Pages 1546-1554Publisher
WILEY
DOI: 10.1111/all.14336
Keywords
allergy treatment; clinical immunotherapy; immunotherapy vaccines and mechanisms
Categories
Ask authors/readers for more resources
The current COVID-19 pandemic influences many aspects of personal and social interaction, including patient contacts with health care providers and the manner in which allergy care is provided and maintained. Allergen-specific immunotherapy (AIT) is one of the most important treatment options for IgE-mediated allergies and is based on inducing an appropriate immune response in the allergic patient. This manuscript outlines the EAACI recommendations regarding AIT during the COVID-19 pandemic and aims at supporting allergists and all physicians performing AIT in their current daily practice with clear recommendations on how to perform treatment during the pandemic and in SARS-CoV-2 infected patients.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available